Navigation Links
Innocoll Announces Dosing of Last Patient in US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Cardiac Surgery Patients
Date:3/16/2009

rights to its lead product, CollaRx GENTAMICIN SURGICAL IMPLANT to Baxter Healthcare, a division of Baxter International Inc (NYSE: BAX) The product is currently in phase 3 development in the US for the prevention of surgical site infections. It is approved for sale in 49 countries in Europe, Latin America, Middle East, Africa and Asia. Other late stage pharmaceutical products in Innocoll's development pipeline include CollaRx Gentamicin Topical for the treatment and prevention of infected diabetic foot ulcers and CollaRx Bupivacaine Implant for the management of post-operative pain, both of which are currently in Phase 2 development. For more information, please visit www.innocollinc.com.


'/>"/>
SOURCE Innocoll, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain
2. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Prevention of Diabetic Foot Infections
3. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers
4. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
5. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
6. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
7. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
8. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
9. YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
10. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours
11. InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... 2015 A global continuing medical ... and thyroid disorders in Central and South-East ... a major conference dedicated to these diseases. ... Online , Manage Hypertension Online and ... by EXCEMED - combine the world,s top ...
(Date:7/3/2015)... July 3, 2015 Un ... épidémies que sont l,hypertension, le diabète et les ... plateformes éducatives gratuites et d,une conférence majeure dédiée ... http://photos.prnewswire.com/prnh/20150630/227033 ) , Les formations ... , Prendre en charge l,hypertension en ligne ...
(Date:7/3/2015)... 3, 2015 Der ... bestimmter Abschlussbedingungen eine 100-prozentige Beteiligung am Unternehmen ... Mit dieser Übernahme dringt Lupin in den ... von 765 Mrd. RUB im Jahr 2014 ... gehörte (IMS Health). Seit über einem Jahrzehnt ...
Breaking Medicine Technology:Combating Three Major Chronic Diseases in Central and South-East Asia With Medical Education 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3Lupin übernimmt Biocom aus Russland 2Lupin übernimmt Biocom aus Russland 3
... PITTSBURGH, Oct. 13 BIOSAFE, Inc. , a ... has announced that they are launching in specific markets ... with BIOSAFE (®) . Crosstex, new BIOSAFE-treated Ultra ... VRE, and Staph immediately upon contact, and have further ...
... Sangamo BioSciences, Inc. (Nasdaq: SGMO ) today announced ... 3,000,000 shares of its common stock at a price ... from the sale of shares in this offering, after ... expenses, were approximately $20.9 million. Sangamo intends to use ...
Cached Medicine Technology:BIOSAFE Launching In a New Specially-Treated Facemask Effective Against H1N1 Influenza 2BIOSAFE Launching In a New Specially-Treated Facemask Effective Against H1N1 Influenza 3BIOSAFE Launching In a New Specially-Treated Facemask Effective Against H1N1 Influenza 4Sangamo Announces Closing of Common Stock Offering 2Sangamo Announces Closing of Common Stock Offering 3
(Date:7/5/2015)... MN (PRWEB) , ... July 06, 2015 , ... ... the ancillary benefits market, is excited to announce the next generation of PrimeStar ... and Advantage plans to now include two network options—Maximum Allowable Charge (MAC) and ...
(Date:7/5/2015)... Raleigh, NC (PRWEB) , ... July 05, 2015 , ... ... good data-gathering, a new IMRT/surgery combination may one day change the outlook for people ... to read it now. , Researchers report that five mesothelioma patients treated ...
(Date:7/4/2015)... , ... July 04, 2015 , ... ... solar industry’s leading recognition of technical sales expertise from the North American Board ... Sales ProfessionalTM. NABCEP is the most highly respected and well established national certification ...
(Date:7/3/2015)... ... July 03, 2015 , ... Scientists at several top US cancer centers believe ... asbestos exposure. Click here to read the complete story , just posted on ... Cedars Sinai Medical Center, and New York University exposed mice with a mutation on ...
(Date:7/3/2015)... , ... July 03, 2015 , ... Smoothies are all ... a good blender and easily accessible, quality ingredients. Aurora Natural is proud to introduce ... an added boost of fiber, protein, antioxidants, vitamins and minerals! , Aurora is offering ...
Breaking Medicine News(10 mins):Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2Health News:New Mesothelioma Study Calls IMRT/Surgery Combo “Innovative and Promising”, According to Surviving Mesothelioma 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2
... /PRNewswire-FirstCall/ - MDS Nordion, a leading,provider of ... to their medical isotope customers about a ... from their primary supplier regarding,an interruption in ... manufacturing of,technetium-99m generators and iodine-131. The primary ...
... States,Golf Association (USGA) awarded a $20,000 matching grant to ... Program and the creation of a golf program at ... the USGA has supported programs that bring the game,of ... PGA Golf Pro,who leads the Winter Therapeutic Golf Clinics ...
... Nov. 30 Journalists from leading U.S.,news organizations ... organized by the,United Nations and the National Association ... on the impact of climate change, the fight ... the framework of the Millennium Development Goals (MDGs)., ...
... MD (November 30, 2007) Concerns over possible radiation effects ... New England Journal of Medicine should not scare people away ... a critical role in saving the lives of thousands of ... Association of Physicists in Medicine (AAPM). , In a statement ...
... a third, study found , , FRIDAY, Nov. 30 (HealthDay ... significantly slows the decline in lung function seen in ... team at Case Western Reserve University School of Medicine, ... took high doses of ibuprofen twice a day had ...
... Caraco Pharmaceutical,Laboratories, Ltd., (Amex: CPD ) announced ... has granted tentative approval for the Company,s,Abbreviated New ... mg, 10 mg, and 20 mg., Escitalopram ... This tentative approval is for the generic bioequivalent ...
Cached Medicine News:Health News:MDS Nordion Provides Update to Medical Isotope Customers 2Health News:Marianjoy Rehabilitation Hospital Therapeutic Golf Program Receives a $20,000 Matching Grant From the USGA 2Health News:NABJ Joins with U.N. to Cover Climate Change and Development in Senegal 2Health News:NABJ Joins with U.N. to Cover Climate Change and Development in Senegal 3Health News:Hazards of CT scans overstated 2Health News:Ibuprofen Preserves Lung Function in Kids With Cystic Fibrosis 2Health News:Ibuprofen Preserves Lung Function in Kids With Cystic Fibrosis 3Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R) 2
Features four-way apron closure for super adjustability to fit staff of all shapes and sizes. Top left and right shoulder closures allow adjustment of armhole size and chest area of apron for close a...
Freedom of movement - plus full circle, maximum radiation protection. No other full circle radiation protection design approaches the level of comfort of the VestSkirt, which divides weight between t...
Use this workhorse apron where 360 of protection from direct and scatter radiation is required....
Bio-Rad's Genetic Systems™ HBsAg EIA 3.0 screening and confirmatory assays offer outstanding sensitivity and early detection of HBV infection, helping to meet your testing criteria....
Medicine Products: